Piper Jaffray & Co. »

Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Piper Jaffray & Co.

Quarter-by-quarter ownership of Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Piper Jaffray & Co. from 13F filings

Historical chart of Piper Jaffray & Co. investment in Neurocrine Biosciences Inc Note 2.250 5/1

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences Inc Note 2.250 5/1 held by Piper Jaffray & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences Inc Note 2.250 5/1 by Piper Jaffray & Co.

Quarter filed Position value Share count Share price at filing
2024-03-31 $25M 14M 1.81

More positions owned by Piper Jaffray & Co.

Palo Alto Networks Note 0.375% 6/0 (Principal)
Neurocrine Biosciences Note 2.250% 5/1 (Principal)
Pioneer Nat Res Note 0.250% 5/1 (Principal)
Mfa Finl Note 6.250% 6/1 (Principal)
Pennymac Corp Note 5.500%11/0 (Principal)
Chegg Note 0.125% 3/1 (Principal)
Jazz Investments I Note 1.500% 8/1 (Principal)
Paramount Global 5.75% Conv Pfd A (PARAP)
Bilibili Note 1.375% 4/0 (Principal)
Kaman Corp Note 3.250% 5/0 (Principal)
Arbor Realty Trust Note 7.500% 8/0 (Principal)
Turning Pt Brands Note 2.500% 7/1 (Principal)
Redwood Trust Note 5.625% 7/1 (Principal)
Shattuck Labs (STTK)
Prospect Cap Corp Note 6.375% 3/0 (Principal)

View all positions for Piper Jaffray & Co.

Top funds holding Neurocrine Biosciences Inc Note 2.250 5/1

Franklin Resources
Tenor Capital Management
D. E. Shaw & Co
Piper Jaffray & Co.
FMR
Lord, Abbett & Co
T. Rowe Price Associates
SSI Investment Management
Bnp Paribas Investment Partners
Agf Management
Rock Springs Capital Management
Citigroup
Barclays
Jane Street
American Century Companies

View all funds holding Neurocrine Biosciences Inc Note 2.250 5/1